(Q42437288)

31 October 2017

A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels (English)

1 reference

31 October 2017

0 references

7

Undine E Lang

1 reference

31 October 2017

Olga Fedorenko

1

1 reference

31 October 2017

Nathalie Strutz-Seebohm

2

1 reference

31 October 2017

Ulrike Henrion

3

1 reference

31 October 2017

Oana N Ureche

4

1 reference

31 October 2017

Florian Lang

5

1 reference

31 October 2017

Guiscard Seebohm

6

1 reference

31 October 2017

11 June 2008

1 reference

31 October 2017

1 reference

31 October 2017

199

1 reference

31 October 2017

47-54

1 reference

31 October 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-008-1095-x

31 October 2017

0 references

cites work

Retigabine: chemical synthesis to clinical application.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1095-X

Prediction of relapse in schizophrenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1095-X

The PIP5K2A gene and schizophrenia in the Chinese population--a case-control study

21 January 2018

1 reference

12 December 2020

Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes.

1 reference

12 December 2020

Pathways modulating neural KCNQ/M (Kv7) potassium channels

1 reference

12 December 2020

PIP(2) and proteins: interactions, organization, and information flow

1 reference

12 December 2020

Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.

1 reference

12 December 2020

K(v)7 channels: function, pharmacology and channel modulators.

1 reference

12 December 2020

Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase

1 reference

12 December 2020

Characterization of M-current in ventral tegmental area dopamine neurons.

1 reference

12 December 2020

The KCNQ channel activator retigabine blocks haloperidol-induced c-Fos expression in the striatum of the rat.

1 reference

12 December 2020

Acute psychosis leads to increased QT variability in patients suffering from schizophrenia

1 reference

12 December 2020

Causative and preventive action of calcium in cataracto-genesis.

1 reference

12 December 2020

Novel targets for drugs in schizophrenia

1 reference

12 December 2020

A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate

1 reference

12 December 2020

KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission.

1 reference

12 December 2020

M-channels (Kv7/KCNQ channels) that regulate synaptic integration, excitability, and spike pattern of CA1 pyramidal cells are located in the perisomatic region.

1 reference

12 December 2020

Neurobiology of dopamine in schizophrenia

1 reference

12 December 2020

Membrane ruffling requires coordination between type Ialpha phosphatidylinositol phosphate kinase and Rac signaling

1 reference

12 December 2020

Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p‐Linked Psychiatric Disorders

1 reference

12 December 2020

Clozapine: guidelines for clinical management

1 reference

12 December 2020

Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia

1 reference

12 December 2020

Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels

1 reference

12 December 2020

Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum

1 reference

12 December 2020

Pathophysiology of KCNQ Channels: Neonatal Epilepsy and Progressive Deafness

1 reference

12 December 2020

Distinct specificities of inwardly rectifying K(+) channels for phosphoinositides

1 reference

12 December 2020

Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.

1 reference

12 December 2020

Molecular mechanisms of schizophrenia

1 reference

12 December 2020

The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.

1 reference

12 December 2020

Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.

1 reference

12 December 2020

Psychosis among substance users.

1 reference

12 December 2020

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

1 reference

12 December 2020

The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat

1 reference

12 December 2020

Ion channel defects in idiopathic epilepsies

1 reference

12 December 2020

Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.

1 reference

12 December 2020

Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs

1 reference

12 December 2020

Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia

1 reference

12 December 2020

PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents

1 reference

12 December 2020

Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy

1 reference

12 December 2020

[KCNQ 1 (KvLQT1) missense mutation causing congenital long QT syndrome (Jervell-Lange-Nielsen) in a Mexican family]

1 reference

12 December 2020

The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia

1 reference

12 December 2020

Regulation of M(Kv7.2/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition

1 reference

12 December 2020

The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins

1 reference

12 December 2020

10.1007/S00213-008-1095-X

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

0 references

1 reference